Related Experiment Video

Updated: Jun 14, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
09:31

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses

Published on: March 30, 2015

8.9K

The value of IMmotion010 for rare kidney cancer histologies - Authors' reply

Robert Uzzo1, Axel Bex2, Sumanta K Pal3

  • 1Department of Urology, Fox Chase Cancer Center Philadelphia, PA, USA.

Lancet (London, England)
|July 15, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K
Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

690

Related Experiment Videos

Last Updated: Jun 14, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
09:31

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses

Published on: March 30, 2015

8.9K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K
Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
06:29

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

690

Related Concept Videos

Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...

Articles linked to this work by shared authors, journal, and citation graph.

Dynamic Adaptations of the Thoracolumbar Junction: A Cross-Sectional Analysis of Vertebral Pelvic Angle Changes from Standing to Sitting.

Spine·2026

Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma.

European urology oncology·2026

Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

The Lancet. Oncology·2026

Salvage therapies for local recurrence of renal cell carcinoma: a systematic review and meta-analysis.

World journal of urology·2026

Influence of primary language on follow-up after emergency department visits for acute renal colic: evidence from an ethnically diverse urban cohort.

World journal of urology·2026

Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making.

European urology·2026

Understanding peripheral arterial disease in the current era.

Lancet (London, England)·2026

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Lancet (London, England)·2026

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Lancet (London, England)·2026

Developing roadmaps for advancing practice, research, and policy in the arts and health.

Lancet (London, England)·2026

Precision prevention and early detection: framework for a new clinical cancer control pathway.

Lancet (London, England)·2026

Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

Lancet (London, England)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us